Evidence map›Paper›PMID 42658406›Full record

ArticlePhysical and engineering sciences in medicine2026

A comparative study of vision transformer architectures for the detection of Alzheimer's disease using magnetic resonance images.

Murat Uçar

Abstract read
PubMed Publisher
In one paragraph

Article in Physical and engineering sciences in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Murat UçarDepartment of Computer Engineering, Faculty of Engineering and Architecture, İzmir Bakırçay University, İzmir, Turkey. murat.ucar@bakircay.edu.tr.ORCID http://orcid.org/0000-0001-9997-4267

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease is a neurodegenerative disease that affects millions of people worldwide. With the increasing global elderly population, early and accurate diagnosis of the disease is becoming increasingly important to slow its progression and improve patient outcomes. This study aims to present a comprehensive vision transformer-based solution proposal for the accurate and rapid detection of Alzheimer's disease using magnetic resonance images. Nine different transformer-based models, namely Vision Transformer, Pooling-based Vision Transformer, Convolutional Vision Transformer, Crossformer, Cross-attention Vision Transformer, Nested Transformers, Multi-Axis Vision Transformer, Separable Vision Transformer, and MobileViT, were used to analyse their effectiveness in diagnosing the disease in detail. Experimental results have shown that transformer-based architectures exhibit high performance in the detection of Alzheimer's disease. In binary classification results, the Multi-Axis Vision Transformer model stood out from other models by achieving the most successful performance in accuracy, sensitivity, specificity, precision, and f1-score metrics. In multi-class classification results, the Crossformer model provided the highest results in terms of sensitivity, specificity, precision, and f1-score, while the Separable Vision Transformer model was the most successful model in the accuracy metric. Furthermore, it was observed that the Mobile Vision Transformer model produced competitive results, especially in sensitivity and specificity metrics. In conclusion, this study provides a promising framework for the use of vision transformers in neuroimaging, providing an innovative solution for the early diagnosis of Alzheimer's disease.

Indexed as

Alzheimer's diseaseDeep learningMRI classificationVision transformer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.